Tags

Type your tag names separated by a space and hit enter

Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.
AAPS PharmSciTech. 2011 Sep; 12(3):1011-8.AP

Abstract

Tetrandrine (TET) is a poorly water-soluble bisbenzylisoquinoline alkaloid. In this study, TET solid lipid nanoparticles (SLNs) were prepared by a melt-emulsification and ultrasonication technique. Precirol(®) ATO 5, glyceryl monostearate, and stearic acid were used as the lipid matrix for the SLNs, while Lipoid E80, Pluronic F68, and sodium deoxycholate were used as emulsifying and stabilizing agents. The physicochemical characteristics of the TET-SLNs were investigated when it was found that the mean particle size and zeta potential of the TET-SLNs were 134 ± 1.3 nm and -53.8 ± 1.7 mV, respectively, and the entrapment efficiency (EE) was 89.57% ± 0.39%. Differential scanning calorimetry indicated that TET was in an amorphous state in SLNs. TET-SLNs exhibited a higher release rate at a lower pH and a lower release rate at a higher pH. The release pattern of the TET-SLNs followed the Weibull model. The pharmacokinetics of TET-SLNs after intravenous administration to male rats was studied. TET-SLN resulted in a higher plasma concentration and lower clearance. The biodistribution study indicated that TET-SLN showed a high uptake in reticuloendothelial system organs. In conclusion, TET-SLNs with a small particle size, and high EE, can be produced by the method described in this study. The SLN system is a promising approach for the intravenous delivery of tetrandrine.

Authors+Show Affiliations

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, People's Republic of China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

21811889

Citation

Li, Su, et al. "Preparation, Characterization, Pharmacokinetics and Tissue Distribution of Solid Lipid Nanoparticles Loaded With Tetrandrine." AAPS PharmSciTech, vol. 12, no. 3, 2011, pp. 1011-8.
Li S, Ji Z, Zou M, et al. Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech. 2011;12(3):1011-8.
Li, S., Ji, Z., Zou, M., Nie, X., Shi, Y., & Cheng, G. (2011). Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech, 12(3), 1011-8. https://doi.org/10.1208/s12249-011-9665-3
Li S, et al. Preparation, Characterization, Pharmacokinetics and Tissue Distribution of Solid Lipid Nanoparticles Loaded With Tetrandrine. AAPS PharmSciTech. 2011;12(3):1011-8. PubMed PMID: 21811889.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AU - Li,Su, AU - Ji,Zhaoshuai, AU - Zou,Meijuan, AU - Nie,Xin, AU - Shi,Yijie, AU - Cheng,Gang, Y1 - 2011/08/03/ PY - 2011/05/05/received PY - 2011/07/22/accepted PY - 2011/8/4/entrez PY - 2011/8/4/pubmed PY - 2012/3/27/medline SP - 1011 EP - 8 JF - AAPS PharmSciTech JO - AAPS PharmSciTech VL - 12 IS - 3 N2 - Tetrandrine (TET) is a poorly water-soluble bisbenzylisoquinoline alkaloid. In this study, TET solid lipid nanoparticles (SLNs) were prepared by a melt-emulsification and ultrasonication technique. Precirol(®) ATO 5, glyceryl monostearate, and stearic acid were used as the lipid matrix for the SLNs, while Lipoid E80, Pluronic F68, and sodium deoxycholate were used as emulsifying and stabilizing agents. The physicochemical characteristics of the TET-SLNs were investigated when it was found that the mean particle size and zeta potential of the TET-SLNs were 134 ± 1.3 nm and -53.8 ± 1.7 mV, respectively, and the entrapment efficiency (EE) was 89.57% ± 0.39%. Differential scanning calorimetry indicated that TET was in an amorphous state in SLNs. TET-SLNs exhibited a higher release rate at a lower pH and a lower release rate at a higher pH. The release pattern of the TET-SLNs followed the Weibull model. The pharmacokinetics of TET-SLNs after intravenous administration to male rats was studied. TET-SLN resulted in a higher plasma concentration and lower clearance. The biodistribution study indicated that TET-SLN showed a high uptake in reticuloendothelial system organs. In conclusion, TET-SLNs with a small particle size, and high EE, can be produced by the method described in this study. The SLN system is a promising approach for the intravenous delivery of tetrandrine. SN - 1530-9932 UR - https://www.unboundmedicine.com/medline/citation/21811889/Preparation_characterization_pharmacokinetics_and_tissue_distribution_of_solid_lipid_nanoparticles_loaded_with_tetrandrine_ L2 - https://dx.doi.org/10.1208/s12249-011-9665-3 DB - PRIME DP - Unbound Medicine ER -